InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Rahul Khara. Director active across 3 companies, notably Disc Medicine, Inc.. Cumulatively, 3 filings have been published. History available since 18 June 2026. The latest transaction was disclosed on 6 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条